The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to adults over 65 and people who are high risk. The move is a significant shift away from the current approach of universally green-lighting the shots,

Pandemic-relief funds in 16 states have been temporarily restored—again—just days before they were set to expire.

The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American “repeat-boosters-in-perpetuity

HHS Secretary Robert F. Kennedy Jr. outlines reasons for U.S. withdrawal from WHO, highlighting failures in COVID-19 response and China's influence on the organization.

Elon Musk says he's committed to being CEO of Tesla in five years' time. US regulators say annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved US regulators say annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved.

Punitive measures against the Chinese economy won’t bring back the victims of COVID — but they must not be forgotten: That’s part of the moral imperative to constraining Beijing.

Amid a deluge of cuts to federal spending, the Trump administration has canceled three grants totaling $85.6 million to Santa Clara County that helped fund public health initiatives related to the COVID-19 pandemic and vaccines.